Apr 23, 2026 09:00AM
Apr 15, 2026 09:02AM
Jan 20, 2026 08:38AM
Jan 15, 2026 04:22PM
Jan 12, 2026 08:33AM
Dec 2, 2025 08:06AM
Dec 2, 2025 08:00AM Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045
Nov 11, 2025 08:45AM
Nov 6, 2025 04:28PM
Nov 6, 2025 04:28PM
Oct 30, 2025 09:15AM
Oct 14, 2025 08:45AM
Oct 7, 2025 08:45AM
Oct 7, 2025 08:45AM Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
Oct 1, 2025 04:20PM
Sep 30, 2025 06:49AM
Sep 29, 2025 07:19AM
Aug 13, 2025 06:53PM
Aug 7, 2025 01:10PM
May 8, 2025 05:09PM
May 1, 2025 08:30AM Dogwood Therapeutics, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference
Apr 23, 2025 06:35AM
Apr 11, 2025 09:15AM
Apr 3, 2025 09:00AM
Mar 18, 2025 08:45AM
Mar 13, 2025 09:02AM
Mar 12, 2025 08:31AM
Jan 23, 2025 12:42PM Dogwood Therapeutics (DWTX) Halted on Volatility, Up 552%
Nov 18, 2024 08:46AM
Oct 30, 2024 09:16AM
Oct 7, 2024 07:06AM

401,260 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All